🇩🇪Germany

Verspätete MDR-Meldung und BfArM-Bußgelder

4 verified sources

Definition

Medical device manufacturers in Germany must establish documented complaint handling procedures under ISO 13485:2016 Clause 8.2.2 and report serious incidents to BfArM per MPDG Chapter 5. Manual ticket-based systems create bottlenecks in evaluation, investigation, and reportability determination. Delays in notifying BfArM of suspected serious incidents breach MDR Article 87 notification timelines, triggering administrative penalties under Arbeitsrecht and product liability exposure.

Key Findings

  • Financial Impact: €10,000–€50,000 per late report; typical fine range €5,000–€100,000 depending on severity and repeat violations; plus product recall costs averaging €250,000–€1,000,000+
  • Frequency: Per incident (estimated 2–5 serious complaints per manufacturer annually in regulated classes IIb/III)
  • Root Cause: Manual complaint triage delays risk assessment; unclear workflows prevent timely reportability determination; no automated escalation to compliance officer

Why This Matters

This pain point represents a significant opportunity for B2B solutions targeting Medical Equipment Manufacturing.

Affected Stakeholders

Regulatory Affairs Manager, Quality Assurance Lead, BfArM Liaison Officer, Complaint Handler

Deep Analysis (Premium)

Financial Impact

Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.

Unlock to reveal

Current Workarounds

Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.

Unlock to reveal

Get Solutions for This Problem

Full report with actionable solutions

$99$39
  • Solutions for this specific pain
  • Solutions for all 15 industry pains
  • Where to find first clients
  • Pricing & launch costs
Get Solutions Report

Methodology & Sources

Data collected via OSINT from regulatory filings, industry audits, and verified case studies.

Evidence Sources:

Related Business Risks

Request Deep Analysis

🇩🇪 Be first to access this market's intelligence